MOTS-c affects mitochondrial function and metabolism differently than AOD 9604
No long international delays, no customs issues
Stability: Lyophilized form remains stable when stored under recommended conditions
Backed by the latest scientific research, BPC-157 has demonstrated its ability to accelerate healing, reduce fibrosis, and modulate inflammation, making it a powerful tool for holistic health
The longer, more impassioned answer: Were a compounding pharmacy, which means we offer flexibility that most big pharma options simply cant
Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase